DYN

Dyne Therapeutics
DYN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$1.34B
EV
$690.51M
Shares Outstanding
113.67M
Beta
1.19

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$46.64
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Dyne Therapeutics, Inc.

gainify
DYN

Dyne Therapeutics, Inc.

DYN

Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, inclu...

Sector

Healthcare

Industry

Biotechnology

CEO

Cox, John

Employees

192

IPO Date

2020-09-17

Headquarters

1560 Trapelo Road, Waltham, Massachusetts, 02451, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on Threads
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.